基于动态多维时序数据的高阶收敛LM神经网络构建名中医辨证论治模型研究—以特发性肺纤维化为例
批准号:
82105054
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
叶桦
依托单位:
学科分类:
中医学研究新技术与新方法
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
叶桦
中文摘要
特发性肺纤维化(IPF)属病因不明的呼吸系统难治性疾病,中医特别是名(老)中医诊疗对改善患者临床症状有明显效果。辨证论治是中医学的精髓,证候是其中的关键要素,如何将名医的宝贵诊疗经验客观化?课题组前期对名中医治疗IPF文献医案(116例)和首届全国名中医张之文治疗该病的回顾性病例(79例)进行数据挖掘研究(仅选取首诊次),发现名医诊疗该病在辨证和论治方面存在一定的共性规律。慢性难治疾病的真实临床诊疗呈现多诊次(不同时序)证候发展变化的特点,医家的“论治”也会随之变化,不同时间序列的辨证和论治是否有变化规律可循?结合前期研究基础,本项目拟运用多维关联规则分析影响IPF证候分类的核心症状和辨治不同证候的核心方药,通过收敛速度更快、拟合度更优和预测精度更高的高阶收敛LM神经网络,基于多维时序数据构建“症-证-治-方”模型,探索名中医辨证论治的动态变化规律,提升中医药防治重大疑难疾病的能力。
英文摘要
Idiopathic Pulmonary Fibrosis (IPF) is a refractory disease of respiratory system with unknown etiology. The diagnosis and treatment of TCM physicians, especially famous(old) TCM physicians have noticeable effect in improving patients' clinical symptoms. Syndrome differentiation and treatment are the essences of TCM and syndromes are the key elements. How do we objectify the valuable experience in diagnosis and treatment of famous TCM physicians? Through data mining, our research team selectively studied the first-diagnosis cases of 116 cases in medical literature of the treatment of IPF by famous TCM physicians and 79 retrospective cases treated by Dr. Zhang Zhiwen who is one of the first national famous TCM physicians. We found that there are common rules in syndrome differentiation and treatment of famous TCM physicians. The real clinical diagnosis and treatment of chronic refractory disease have multi-diagnosis and different time-series development of syndromes and the 'diagnosis and treatment' change accordingly. Are there rules to follow for the syndrome differentiation and treatment with different time series? On the basis of previous research, this project intends to discover the core symptoms affecting the syndrome classification of IPF and core prescription for differentiating and treating different syndromes, construct the model of syndrome differentiation and treatment of ‘symptom-syndrome-treatment-prescription’ based on the dynamic and multi-dimensional time-series data through L-M neural network of higher order convergence with higher speed of convergence, better degree of fitting and higher prediction accuracy. Thus, this project intends to explore the dynamic change rules of TCM syndrome differentiation and treatment and improve the dynamic change rules of TCM syndrome differentiation and treatment and improves the abilities for prevention and treatment of major and difficult diseases with Chinese medicine.
特发性肺纤维化(Idiopathic Pulmonary Fibrosis,IPF)属病因不明的呼吸系统复杂难治性疾病,目前临床尚未发现特效治疗药,辨证论治思想指导下的中医药治疗能够改善患者临床症状和提高生活质量,具有重要意义。近年来,人工智能技术的飞速发展为IPF诊疗带来了新的机遇,通过机器学习算法从复杂数据中提取特征,可辅助医生提高诊断准确率和优化治疗方案,降低误诊或误治的风险。本项目基于中医药治疗IPF的理论基础,结合高阶收敛Levenberg-Marquardt(LM)算法,针对多维时序数据开展研究,旨在探索影响IPF证候分类的核心症状以及辨治不同证候的核心方药,通过建立智能辨证、治法预测和药物推荐三种机器学习模型,揭示中医辨证论治IPF的动态变化规律,在智能辅助诊疗方面取得了一定的创新发现。项目收集956例名中医治疗IPF的临床有效病例,应用名医传承平台(FangNet)挖掘出沙参-麦冬、丹参-川芎等核心药对,并首次系统验证了名医经验方二冬二母散的抗纤维化机制。利用Mean Impact Value(MIV)算法评估症状对证候分类的影响权重,筛选出核心症状。通过高阶收敛LM算法优化神经网络模型的拟合度与预测精度,构建智能辨证模型,其预测准确率为81.22%,解决了辨证论治过程中数据冗余和模型可解释性低等问题,为IPF的证候诊断提供了科学依据。基于此模型,进一步结合多种机器学习算法建立‘症-证-治-方’决策模型,实现诊疗方案的动态推荐。本项目创新性地提出一种全流程的智能辨证论治模型,能够综合患者症状和证候信息推荐适宜治疗方案,为中医药治疗复杂疾病提供了新的方法和技术手段。项目组共发表3篇学术论文,包括1篇SCI和2篇北大核心期刊论文;申请中国发明专利2项(授权1项),获得外观设计专利授权1项,软件著作权5项;联合培养博士后2名,指导硕士研究生2名,为中医药智能化研究领域提供了专业人才支持,加强机器学习与中医药结合的学术交流和技术推广,提升中医药防治重大疑难疾病的能力。
国内基金
海外基金